- Home
- PLX vs GLQ Comparison
PLX vs GLQ Comparison
Compare PLX & GLQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLX | GLQ |
|---|---|---|
| Founded | 1993 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.9M | 152.2M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | PLX | GLQ |
|---|---|---|
| Price | $2.35 | $8.35 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 686.8K | 47.7K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.11% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $52,744,000.00 | N/A |
| Revenue This Year | $36.81 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.74 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.47 | $7.14 |
| 52 Week High | $3.19 | $8.75 |
Technical Indicators
Market Signals| Indicator | PLX | GLQ |
|---|---|---|
| Relative Strength Index (RSI) | 48.40 | 50.76 |
| Support Level | $2.19 | $8.02 |
| Resistance Level | $2.43 | $8.35 |
| Average True Range (ATR) | 0.13 | 0.12 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 28.71 | 67.74 |
Price Performance
Historical ComparisonAbout PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
About GLQ Clough Global Equity Fund Clough Global Equity Fund of Beneficial Interest
Clough Global Equity Fund is a closed-end management investment company. Its investment objective is to provide a high level of total return. The Fund invests in the equity, equity-related securities, and fixed-income securities in both U.S. and non-U.S. markets.